Highly Efficient Induction and Long-term Maintenance of Multipotent Cardiovascular Progenitors from Human Pluripotent Stem Cells Under Defined Conditions

Overview

Journal Cell Res

Specialty Cell Biology

Date 2013 Jul 31

PMID 23896987

Citations 77

Authors

Nan Cao

He Liang

Jijun Huang

Jia Wang

Yixiong Chen

Zhongyan Chen

Huang-Tian Yang

Affiliations

Soon will be listed here.

Abstract

Cardiovascular progenitor cells (CVPCs) derived from human pluripotent stem cells (hPSCs), including human embryonic stem cells (hESCs) and human induced pluripotent stem cells (hiPSCs), hold great promise for the study of cardiovascular development and cell-based therapy of heart diseases, but their applications are challenged by the difficulties in their efficient generation and stable maintenance. This study aims to develop chemically defined systems for robust generation and stable propagation of hPSC-derived CVPCs by modulating the key early developmental pathways involved in human cardiovascular specification and CVPC self-renewal. Herein we report that a combination of bone morphogenetic protein 4 (BMP4), glycogen synthase kinase 3 (GSK3) inhibitor CHIR99021 and ascorbic acid is sufficient to rapidly convert monolayer-cultured hPSCs, including hESCs and hiPSCs, into homogeneous CVPCs in a chemically defined medium under feeder- and serum-free culture conditions. These CVPCs stably self-renewed under feeder- and serum-free conditions and expanded over 10(7)-fold when the differentiation-inducing signals from BMP, GSK3 and Activin/Nodal pathways were simultaneously eliminated. Furthermore, these CVPCs exhibited expected genome-wide molecular features of CVPCs, retained potentials to generate major cardiovascular lineages including cardiomyocytes, smooth muscle cells and endothelial cells in vitro, and were non-tumorigenic in vivo. Altogether, the established systems reported here permit efficient generation and stable maintenance of hPSC-derived CVPCs, which represent a powerful tool to study early embryonic cardiovascular development and provide a potentially safe source of cells for myocardial regenerative medicine.

Citing Articles

SMYD1 modulates the proliferation of multipotent cardiac progenitor cells derived from human pluripotent stem cells during myocardial differentiation through GSK3β/β-catenin&ERK signaling.

Chang Y, Bai R, Zhang Y, Lu W, Ma S, Zhu M Stem Cell Res Ther. 2024; 15(1):350.

PMID: 39380045 PMC: 11462858. DOI: 10.1186/s13287-024-03899-7.

Expandable hESC-derived cardiovascular progenitor cells generate functional cardiac lineage cells for microtissue construction.

Rezaeiani S, Rezaee M, Shafaghi M, Karami M, Hamidi R, Khodayari H Stem Cell Res Ther. 2024; 15(1):298.

PMID: 39267174 PMC: 11396807. DOI: 10.1186/s13287-024-03919-6.

Novel Approaches to Program Cells to Differentiate into Cardiomyocytes in Myocardial Regeneration.

Bonavida V, Ghassemi K, Ung G, Inouye K, Thankam F, Agrawal D Rev Cardiovasc Med. 2024; 23(12):392.

PMID: 39076655 PMC: 11270456. DOI: 10.31083/j.rcm2312392.

Cardiovascular Toxicity in Cancer Therapy: Protecting the Heart while Combating Cancer.

Manhas A, Tripathi D, Thomas D, Sayed N Curr Cardiol Rep. 2024; 26(9):953-971.

PMID: 39042344 DOI: 10.1007/s11886-024-02099-2.

Advances in the differentiation of pluripotent stem cells into vascular cells.

Jiao Y, Wang Y, Liu W, Xu J, Zhao Y, Yan C World J Stem Cells. 2024; 16(2):137-150.

PMID: 38455095 PMC: 10915963. DOI: 10.4252/wjsc.v16.i2.137.

References

Mummery C, Zhang J, Ng E, Elliott D, Elefanty A, Kamp T . Differentiation of human embryonic stem cells and induced pluripotent stem cells to cardiomyocytes: a methods overview. Circ Res. 2012; 111(3):344-58. PMC: 3578601. DOI: 10.1161/CIRCRESAHA.110.227512. View

Moretti A, Bellin M, Jung C, Thies T, Takashima Y, Bernshausen A . Mouse and human induced pluripotent stem cells as a source for multipotent Isl1+ cardiovascular progenitors. FASEB J. 2009; 24(3):700-11. DOI: 10.1096/fj.09-139477. View

Cao F, Wagner R, Wilson K, Xie X, Fu J, Drukker M . Transcriptional and functional profiling of human embryonic stem cell-derived cardiomyocytes. PLoS One. 2008; 3(10):e3474. PMC: 2565131. DOI: 10.1371/journal.pone.0003474. View

Burridge P, Thompson S, Millrod M, Weinberg S, Yuan X, Peters A . A universal system for highly efficient cardiac differentiation of human induced pluripotent stem cells that eliminates interline variability. PLoS One. 2011; 6(4):e18293. PMC: 3072973. DOI: 10.1371/journal.pone.0018293. View

Blin G, Neri T, Stefanovic S, Puceat M . Human embryonic and induced pluripotent stem cells in basic and clinical research in cardiology. Curr Stem Cell Res Ther. 2010; 5(3):215-26. DOI: 10.2174/157488810791824584. View

van Laake L, Passier R, Monshouwer-Kloots J, Verkleij A, Lips D, Freund C . Human embryonic stem cell-derived cardiomyocytes survive and mature in the mouse heart and transiently improve function after myocardial infarction. Stem Cell Res. 2009; 1(1):9-24. DOI: 10.1016/j.scr.2007.06.001. View

Minami I, Yamada K, Otsuji T, Yamamoto T, Shen Y, Otsuka S . A small molecule that promotes cardiac differentiation of human pluripotent stem cells under defined, cytokine- and xeno-free conditions. Cell Rep. 2012; 2(5):1448-60. DOI: 10.1016/j.celrep.2012.09.015. View

Blin G, Nury D, Stefanovic S, Neri T, Guillevic O, Brinon B . A purified population of multipotent cardiovascular progenitors derived from primate pluripotent stem cells engrafts in postmyocardial infarcted nonhuman primates. J Clin Invest. 2010; 120(4):1125-39. PMC: 2846046. DOI: 10.1172/JCI40120. View

Bondue A, Blanpain C . Mesp1: a key regulator of cardiovascular lineage commitment. Circ Res. 2010; 107(12):1414-27. DOI: 10.1161/CIRCRESAHA.110.227058. View

10.

Qyang Y, Martin-Puig S, Chiravuri M, Chen S, Xu H, Bu L . The renewal and differentiation of Isl1+ cardiovascular progenitors are controlled by a Wnt/beta-catenin pathway. Cell Stem Cell. 2008; 1(2):165-79. DOI: 10.1016/j.stem.2007.05.018. View

11.

Yang L, Soonpaa M, Adler E, Roepke T, Kattman S, Kennedy M . Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population. Nature. 2008; 453(7194):524-8. DOI: 10.1038/nature06894. View

12.

Bu L, Jiang X, Martin-Puig S, Caron L, Zhu S, Shao Y . Human ISL1 heart progenitors generate diverse multipotent cardiovascular cell lineages. Nature. 2009; 460(7251):113-7. DOI: 10.1038/nature08191. View

13.

Cai C, Liang X, Shi Y, Chu P, Pfaff S, Chen J . Isl1 identifies a cardiac progenitor population that proliferates prior to differentiation and contributes a majority of cells to the heart. Dev Cell. 2003; 5(6):877-89. PMC: 5578462. DOI: 10.1016/s1534-5807(03)00363-0. View

14.

Burridge P, Keller G, Gold J, Wu J . Production of de novo cardiomyocytes: human pluripotent stem cell differentiation and direct reprogramming. Cell Stem Cell. 2012; 10(1):16-28. PMC: 3255078. DOI: 10.1016/j.stem.2011.12.013. View

15.

Sone M, Itoh H, Yamahara K, Yamashita J, Yurugi-Kobayashi T, Nonoguchi A . Pathway for differentiation of human embryonic stem cells to vascular cell components and their potential for vascular regeneration. Arterioscler Thromb Vasc Biol. 2007; 27(10):2127-34. DOI: 10.1161/ATVBAHA.107.143149. View

16.

Noseda M, Peterkin T, Simoes F, Patient R, Schneider M . Cardiopoietic factors: extracellular signals for cardiac lineage commitment. Circ Res. 2011; 108(1):129-52. DOI: 10.1161/CIRCRESAHA.110.223792. View

17.

Li C, Zhou J, Shi G, Ma Y, Yang Y, Gu J . Pluripotency can be rapidly and efficiently induced in human amniotic fluid-derived cells. Hum Mol Genet. 2009; 18(22):4340-9. DOI: 10.1093/hmg/ddp386. View

18.

Cheung C, Bernardo A, Trotter M, Pedersen R, Sinha S . Generation of human vascular smooth muscle subtypes provides insight into embryological origin-dependent disease susceptibility. Nat Biotechnol. 2012; 30(2):165-73. PMC: 3272383. DOI: 10.1038/nbt.2107. View

19.

Kattman S, Witty A, Gagliardi M, Dubois N, Niapour M, Hotta A . Stage-specific optimization of activin/nodal and BMP signaling promotes cardiac differentiation of mouse and human pluripotent stem cell lines. Cell Stem Cell. 2011; 8(2):228-40. DOI: 10.1016/j.stem.2010.12.008. View

20.

Leschik J, Stefanovic S, Brinon B, Puceat M . Cardiac commitment of primate embryonic stem cells. Nat Protoc. 2008; 3(9):1381-7. DOI: 10.1038/nprot.2008.116. View